剪切波色散成像评估非酒精性脂肪性肝病的重复性前瞻性验证
这项前瞻性研究在疑似或拟诊非酒精性脂肪性肝病患者(71例)中由一名放射科医师进行两次剪切波色散成像(SWDI)检查以评估观察者内重复性,并在无症状志愿者(19例)中由三名放射科医师独立进行三次检查以评估观察者间重复性。观察者内组内相关系数(ICC)为0.955(95%CI:0.926-0.973),观察者间ICC为0.800(95%CI:0.572-0.916),提示SWDI具有优秀的观察者内和观察者间重复性。
要点
- SWDI观察者内重复性ICC为0.955(95%CI:0.926-0.973),属优秀水平。
- SWDI观察者间重复性ICC为0.800(95%CI:0.572-0.916),属良好水平。
- 体重指数、超声脂肪变分级及肝功能异常不影响观察者内ICC。
核心结论
- SWDI在评估非酒精性脂肪性肝病时具有优秀的观察者内和观察者间重复性。
研究设计与样本
- 前瞻性研究,经机构审查委员会批准并获所有患者知情同意;组I为疑似或拟诊非酒精性脂肪性肝病患者(n=71),由一名放射科医师进行两次SWDI检查评估观察者内重复性;组II为无症状志愿者(n=19),由三名放射科医师独立进行三次检查评估观察者间重复性;使用商用超声系统,采用组内相关系数(ICC)评估重复性。
诊断标准与关键数值
- 观察者内重复性ICC为0.955(95%CI:0.926-0.973);观察者间重复性ICC为0.800(95%CI:0.572-0.916)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
This study was aimed at evaluating the intra-observer repeatability of shear wave dispersion imaging (SWDI) for evaluation of non-alcoholic fatty liver disease and assessing inter-observer repeatability in asymptomatic volunteers, using a commercial ultrasound system. This prospective study was approved by our institutional review board and informed consent was obtained from all patients. In group I composed of patients with suspected or alleged non-alcoholic fatty liver disease (n = 71), two sessions of SWDI were performed by one radiologist for evaluation of intra-observer repeatability. In group II composed of asymptomatic volunteers (n = 19), three independent sessions were performed by three radiologists. Intra-observer and inter-observer repeatability was assessed using intra-class correlation coefficients (ICCs). For intra-observer repeatability, the ICC was 0.955 (95% confidence interval: 0.926-0.973), and subgroup analysis revealed that body mass index, ultrasound steatosis grade and liver function test abnormalities did not affect ICCs. The ICC for inter-observer repeatability was 0.800 (95% confidence interval: 0.572-0.916). Thus, SWDI had excellent intra-and inter-observer repeatability.
引用
- Yoo J, Lee JM, Joo I, et al. Prospective Validation of Repeatability of Shear Wave Dispersion Imaging for Evaluation of Non-alcoholic Fatty Liver Disease. Ultrasound Med Biol. 2019. PMID: 31320150. doi:10.1016/j.ultrasmedbio.2019.06.411
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。